Radiopharmaceutical: Difference between revisions

Content deleted Content added
m →‎Technetium-99m: Removed more weird periods
 
(47 intermediate revisions by 29 users not shown)
Line 1:
{{Short description|Pharmaceutical drug which emits radiation, used as a diagnostic or therapeutic agent}}
[[File:Radiopharmaceutical.jpg|200px|thumbnail|right| A [[carbon-11]] labelled radiopharmaceutical]]{{Merge from|List of radiopharmaceuticals|date=March 2017}}
[[File:Radiopharmaceutical.jpg|200px|thumbnail|right| A [[carbon-11]] labelled radiopharmaceutical]]{{ATC code V}}'''Radiopharmaceuticals''', or '''medicinal radiocompounds''', are a group of [[pharmaceutical drug]]s which havecontaining [[radioactivityradioactive isotope]]s. Radiopharmaceuticals can be used as [[medical diagnosis|diagnostic]] and [[therapy|therapeutic]] agents. Radiopharmaceuticals emit radiation themselves, which is different from [[contrast media]] which absorb or alter external electromagnetism or ultrasound. [[Radiopharmacology]] is the branch of pharmacology that specializes in these agents.
 
The main group of these compounds are the [[radioactive tracer|radiotracer]]s used to diagnose dysfunction in body [[tissue (biology)|tissues]]. While not all [[medical isotopes]] are radioactive, radiopharmaceuticals are the oldest and stillremain the most common of such drugs.
{{ATC code V}}
 
==Drug nomenclature for radiopharmaceuticals==
 
{{Main|Radiopharmacology#Drug nomenclature for radiopharmaceuticals}}
As with other pharmaceutical drugs, there is [[standardization]] of the [[drug nomenclature]] for radiopharmaceuticals, although various standards coexist. The [[International Nonproprietary Name]]s (INNs), [[United States Pharmacopeia]] (USP) names, and [[International Union of Pure and Applied Chemistry|IUPAC]] names for these agents are usually similar other than trivial style differences.<ref name="AMA_10e_15.9.2">{{Citation |last=Iverson |firsteditor-last=Cheryl,| et al. (eds)display-editors=etal |title=[[AMA Manual of Style]] |edition=10th |publisher=[[Oxford University Press]] |location=Oxford, Oxfordshire |year=2007 |isbn=978-0-19-517633-9 |chapter=15.9.2 Radiopharmaceuticals |chapter-url=http://www.amamanualofstyle.com/ |postscript=.}}</ref> The details are explained at ''[[Radiopharmacology#Drug nomenclature for radiopharmaceuticals|Radiopharmacology § Drug nomenclature for radiopharmaceuticals]]''.
 
==Specific radiopharmaceuticals==
 
A list of '''nuclear medicine radiopharmaceuticals''' follows. Some radioisotopes* are used in [[ion]]ic or [[Chemically inert|inert]] form without attachment to a pharmaceutical,; these are also included. There is a section for each [[radioisotope]] with a table of radiopharmaceuticals using that radioisotope. The sections are ordered alphabetically by the English name of the radioisotope. Sections for the same [[Chemical element|element]] are then ordered by [[atomic mass number]].
 
===Calcium-47===
Line 44 ⟶ 43:
|-
|C11-L-methyl-methionine
|Brain tumour imaging<br />
Parathyroid imaging
|IV
Line 75 ⟶ 74:
|-
|C14-Urea
|Breath test to detect ''[[Helicobacter pylori]]''
|Oral
|''In-vitro''
Line 167 ⟶ 166:
 
===Fluorine-18===
{{further|Positron emission tomography{{!}}Positron emission tomography (PET scan)}}
[[Fluorine-18|<sup>18</sup>F]] is a [[positron]] emitter with a half -life of 109 minutes. It is produced in medical cyclotrons, usually from oxygen-18, and then chemically attached to a pharmaceutical. See [[PET scan]]formulation.
 
{| class="wikitable" style="font-size:95%"
Line 178:
|-
|F18-FDG ([[Fluorodeoxyglucose]])
|Tumor imaging<br />
Myocardial imaging
|IV
Line 204:
 
===Gallium-67===
{{further|Gallium scan}}
[[Gallium|<sup>67</sup>Ga]] is a [[gamma ray|gamma]] emitter. See [[gallium scan]].
 
{| class="wikitable" style="font-size:95%"
Line 228 ⟶ 229:
 
===Gallium-68===
[[Gallium|<sup>68</sup>Ga]] is a [[positron]] emitter, with a 68-minute [[half -life]], produced by [[elution]] from germanium-68 in a [[gallium-68 generator]]. Seeor alsoby [[positronproton emissionirradiation tomography]]of zinc-68.
 
{| class="wikitable" style="font-size:95%"
Line 287 ⟶ 288:
|-
|In111-DTPA ([[DTPA|diethylenetriaminepenta-acetic acid]])
|[[Cisternography]]
|Intra-cisternal
|''In-vivo''
Line 318 ⟶ 319:
 
===Iodine-123===
[[Iodine-123|Iodine-123]] (I-123)]] is a [[gamma ray|gamma]] emitter. It is used only diagnostically, as its radiation is penetrating and short-lived.
 
{| class="wikitable" style="font-size:95%"
Line 335 ⟶ 336:
|-
|I123-Iodide
|Thyroid imaging<br />
Thyroid [[metastasis|metastases]] imaging
|Oral or IV
Line 461 ⟶ 462:
!Route of administration
!''In-vitro'' / ''in-vivo''
!Imaging / non-imaging the radio activeradioactive substance
|-
|Kr81m-Gas
Line 474 ⟶ 475:
|''In-vivo''
|Imaging
|}
 
===Lutetium-177===
[[Lutetium|<sup>177</sup>Lu]] is a [[beta particle|beta]] emitter.
 
{| class="wikitable" style="font-size:95%"
|-
!Name
!Treatment of
!Route of administration
!''In-vitro'' / ''in-vivo''
|-
|[[Lutetium (177Lu) oxodotreotide|<sup>177</sup>Lu-DOTA-TATE]]
|[[Neuroendocrine tumor#Gastroenteropancreatic|gastroenteropancreatic neuroendocrine tumors]] (GEP-NETs)
|IV
|''In-vivo''
|-
|}
 
Line 506 ⟶ 524:
|-
|O15-Water
|Cerebral blood flow imaging<br />
Myocardial blood flow imaging
|IV bolus
Line 547 ⟶ 565:
|-
!Name
!TreatmentInvestigation of
!Route of administration
|-
|[[Rubidium-82 chloride|Rb-82 Chloridechloride]]
|Myocardial Imaging
|IV
Line 644 ⟶ 662:
 
===Technetium-99m===
[[Technetium|<sup>99</sup>Tc-99m]] is a [[gamma ray|gamma]] emitter. It is obtained on-site at the imaging center as the soluble pertechnetate which is eluted from a [[technetium-99m generator]], and then either used directly as this soluble salt, or else used to synthesize a number of [[technetium-99m]]-based radiopharmaceuticals.
 
{| class="wikitable" style="font-size:95%"
Line 651 ⟶ 669:
!Investigation
!Route of administration
!''In-vitro''  / ''in-vivo''
!Imaging  / non-imaging
|-
|Tc99m-[[pertechnetate]]
|[[Thyroid]] uptake and thyroid imaging<br />
Stomach and salivary gland imaging<br />
[[Meckel's diverticulum]] imaging<br />
Brain imaging<br />
Micturating cystogram<br />
First pass blood flow imaging<br />
First pass peripheral vascular imaging
|IV
Line 709 ⟶ 727:
|-
|Tc99m-[[DTPA]] (diethylenetriaminepenta-acetic acid)
|Renal imaging<br />First pass blood flow studies<br />Brain imaging
|IV
|''In-vivo''
Line 733 ⟶ 751:
|-
|Tc99m-Colloid
|Bone marrow imaging<br />
GI Bleeding
|IV
Line 746 ⟶ 764:
|-
|Tc99m-Colloid
|Esophageal transit and reflux imaging<br />
Gastric emptying imaging
|Oral
Line 765 ⟶ 783:
|-
|Tc99m-Denatured (heat damaged) red blood cells
|Red cell volume<br />
Spleen imaging
|IV
Line 772 ⟶ 790:
|-
|Tc99m-Whole red blood cells
|GI bleeding<br />
[[MUGA scan|Cardiac blood pool imaging]]<br />
Peripheral vascular imaging
|IV
Line 780 ⟶ 798:
|-
|Tc99m-MAG3 (mercaptoacetyltriglycine)
|Renal imaging<br />
First pass blood flow imaging<br />
|IV
|''In-vivo''
Line 799 ⟶ 817:
|-
|Tc99m-[[Sestamibi]] (MIBI - methoxy isobutyl isonitrile)
|[[Sestamibi parathyroid scintigraphy|Parathyroid imaging]]<br />
Non-specific tumor imaging<br />
Thyroid tumor imaging<br />
Breast imaging<br />
Myocardial imaging
|IV
Line 827 ⟶ 845:
|-
|Tc99m-Tetrofosmin
|Parathyroid imaging<br />
Myocardial imaging
|IV
Line 852 ⟶ 870:
|-
|Tl201-Tl<sup>+</sup>
|Non-specific tumor imaging<br />
Thyroid tumor imaging<br />
Myocardial imaging<br />
Parathyroid imaging
|IV
Line 911 ⟶ 929:
 
==References==
*{{Reflist}}
 
== External links ==
*[http://www-nds.iaea.org/mib Medical radionuclides production simulator – IAEA ]
 
{{Diagnostic radiopharmaceuticals}}
 
{{Therapeutic radiopharmaceuticals}}
{{Authority control}}
 
[[Category:Radiopharmaceuticals| ]]
[[Category:Radiochemistry| ]]
[[Category:Medicinal chemistry]]
[[Category:Radiochemistry]]
[[Category:Positron emission tomography]]
[[Category:Medical diagnosis]]
[[Category:Drugs by structure]]
[[Category:Molecular imaging]]
[[Category:Medicinal radiochemistry]]
[[Category:PET radiotracers]]
[[Category:Chemicals in medicine]]
[[Category:Isotopes]]